Neurodegeneration and ageing in the HAART era

J Neuroimmune Pharmacol. 2009 Jun;4(2):163-74. doi: 10.1007/s11481-008-9143-1. Epub 2008 Dec 6.


Cognitive impairment and neurodegeneration still occur despite highly active antiretroviral therapy (HAART). While there are many potential reasons for this, there is increasing evidence that such impairment occurs in the absence of a clear cause. Furthermore, there are data that some neurodegenerative diseases, especially Alzheimer's or an Alzheimer-like illness, are becoming more common in the context of HAART-treated human immunodeficiency virus (HIV) disease. This review will critically examine the evidence underpinning these observations. Potential mechanisms will be discussed with particular emphasis on the effect of ageing and how it overlaps with the effects of HIV disease itself thereby leading to neurodegeneration. The nature of this overlap will then be explored for its potential role in the facilitated expression and development of neurodegenerative diseases. Lastly, there will be a brief discussion of interventions to minimize such neurodegeneration including optimization of HAART for brain entry.

Publication types

  • Review

MeSH terms

  • AIDS Dementia Complex / etiology
  • Aging*
  • Antiretroviral Therapy, Highly Active*
  • HIV Infections / complications*
  • HIV Infections / drug therapy*
  • Humans
  • Neurodegenerative Diseases / virology*